Lifesci Index Partners LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lifesci Index Partners LLC
CRD #173705
SEC #801-80539
CIK #0001734312
AUM
Employees 4 (75% Investors, 100% Brokers)
Fees
Minimum
Phone646-597-6979
Address250 W 55th Street
New York, NY 10019
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
705642281402009201420192025
Fees and Compensation — Form ADV Part 2A (3/30/2017) [Brochure]
Item 5 Fees and Compensation
Advisory Services Offered to ETFs
The fees and compensation paid to us by an ETF include a percentage of the assets under our
management as disclosed in each ETF's prospectus. A copy of each prospectus is available through
the SEC's website at www.sec.gov/edgar/searchedgar/companysearch.html. The fees owed to us will
be paid by the ETF in accordance with LifeSci's advisory agreement. Additional fees paid by the ETF
may include, but are not limited to transaction fees such as brokerage and execution charges,
markups, and commissions.

Advisory Services Offered to Funds
The fees and compensation paid to us by the Funds include a fixed percentage fee of 2% of the assets
under our management. Performance fees are also assessed at 20% of the profits and are paid
directly from the Fund's assets. For more information on the performance fee, refer to Item 6 of this
brochure. Additional fees paid by the Fund may include, but are not limited to,legal, audit, and
custodial services provided to the Fund and transaction fees such as brokerage and execution
charges, markups, and commissions. Fee and compensation information is described in each fund's
prospectus. The fees owed to us will be paid by the Funds in accordance with the Fund's LP
agreement.

Compensation for the Sale of Securities or Other Investment Products
Persons providing investment advice on behalf of our firm are registered representatives with a
securities broker-dealer, and a member of the Financial Industry Regulatory Authority and the
Securities Investor Protection Corporation. Compensation earned by these persons in their capacities

as registered representatives is separate and in addition to our advisory fees. This practice presents a
conflict of interest because persons providing investment advice on behalf of our firm who are
registered representatives have an incentive to effect securities transactions for the purpose of
generating commissions rather than solely based on your needs. You are under no obligation,
contractually or otherwise, to purchase securities products through any person affiliated with our firm.

Persons providing investment advice on behalf of our firm may be licensed as independent insurance
agents. These persons will earn commission-based compensation for selling insurance products,
including insurance products they sell to you. Insurance commissions earned by these persons are
separate and in addition to our advisory fees. This practice presents a conflict of interest because
persons providing investment advice on behalf of our firm who are insurance agents may have an
incentive to recommend insurance products to you for the purpose of generating commissions rather
than solely based on your needs. You are under no obligation, contractually or otherwise, to purchase
insurance products through any person affiliated with our firm.
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2017) [Brochure]
Item 7 Types of Clients
We offer investment advisory services to exchange traded funds and pooled investment vehicles (other
than investment companies).
Type Form D Funds Date Sold AUM
VC Lifesci Venture Partners I LP [2017-03-30] 14.0 M 5.0 M
Filed 2018-03-15 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 68.0
By Discretionary
Discretionary 3 68.0
Non-Discretionary 0 0.0
Total 3 68.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 68.0
Total 3 68.0
Form D Directors Role # Filings # Firms 2011 - 2026
Lifesci Venture GP LLC Executive Officer 5 2
Lifesci Index Partners LLC Executive Officer 4 2
EDGAR Form CIK 2011 - 2026
3 [0001734312]
4 [0001734312]
SC 13G [0001734312]
Form 13D/13G Filer Form 13D/13G Subject Filed
Lifesci Index Partners LLC Novus Therapeutics Inc [2018-03-13]
Firm Profile (Form ADV)
ServesInstitutional
Form 3/4/5 Subject 2011 - 2026
Tokai Pharmaceuticals Inc
Lifesci Index Partners LLC
YOOK Paul
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Tokai Pharmaceuticals Inc NVUS
Common Stock, par value $0.01 per share
2019-04-30 Sell 200 $2.70 540
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com